Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Angela C, Rieger"'
Autor:
Angela C. Rieger, Robert J. Myerburg, Victoria Florea, Bryon A. Tompkins, Makoto Natsumeda, Courtney Premer, Aisha Khan, Ivonne H. Schulman, Mayra Vidro-Casiano, Darcy L. DiFede, Alan W. Heldman, Raul Mitrani, Joshua M. Hare
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 377-385 (2019)
Background: Non-ischemic dilated cardiomyopathy (NIDCM) responds variably to intramyocardial injection of mesenchymal stem cells (MSCs). We hypothesized that NIDCM genotype may influence responsiveness to MSC therapy and performed genotyping on all p
Externí odkaz:
https://doaj.org/article/01163b8467294193ba83ca5763e1cefa
Publikováno v:
Rambam Maimonides Medical Journal, Vol 11, Iss 2, p e0015 (2020)
Patients have an ongoing unmet need for effective therapies that reverse the cellular and functional damage associated with heart damage and disease. The discovery that ~1%–2% of adult cardiomyocytes turn over per year provided the impetus for trea
Externí odkaz:
https://doaj.org/article/d9d81a7a50df42ee82d22c5f6ca40e33
Autor:
Angela C Rieger, Bryon A Tompkins, Makoto Natsumeda, Victoria Florea, Monisha N Banerjee, Jose Rodriguez, Marcos Rosado, Valeria Porras, Krystalenia Valasaki, Lauro M Takeuchi, Kevin Collon, Sohil Desai, Michael A Bellio, Aisha Khan, Nilesh D Kashikar, Ana Marie Landin, Darrell V Hardin, Daniel A Rodriguez, Wayne Balkan, Joshua M Hare, Ivonne Hernandez Schulman
Publikováno v:
Stem Cells Translational Medicine. 11:59-72
Background Left ventricular hypertrophy and heart failure with preserved ejection fraction (HFpEF) are primary manifestations of the cardiorenal syndrome in patients with chronic kidney disease (CKD). Therapies that improve morbidity and mortality in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a63346367e949226ebab651b948d508
https://doi.org/10.1093/stcltm/szab004
https://doi.org/10.1093/stcltm/szab004
Autor:
Masatoshi Hotta, Angela C Rieger, Mahbod G Jafarvand, Nandakumar Menon, Andrea Farolfi, Matthias R Benz, Jeremie Calais
Publikováno v:
The British Journal of Radiology. 96
Fibroblast-activation protein (FAP) is a serine protease classified in the dipeptidyl peptidase 4 (DPP4) family. FAP is predominantly expressed in activated fibroblasts such as the cancer-associated fibroblasts (CAFs). FAP expression in CAFs is assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9549db072f30b76579f395def32d39b
https://doi.org/10.1259/bjr.20220463
https://doi.org/10.1259/bjr.20220463
Autor:
Bryon A. Tompkins, Angela C. Rieger, Victoria Florea, Monisha N. Banerjee, Makoto Natsumeda, Evan D. Nigh, Ana Marie Landin, Gianna M. Rodriguez, Konstantinos E. Hatzistergos, Ivonne Hernandez Schulman, Joshua M. Hare
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 14 (2018)
Background Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem cells is safe and provides cardiovascular benefits in both, a comparison of mesen
Externí odkaz:
https://doaj.org/article/f20646039bc24ed7a1aed7ff8eb84856
Publikováno v:
Journal of Nuclear Medicine. 63:180-182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb933ba09ea211b061051f6975a77faa
https://doi.org/10.2967/jnumed.121.263229
https://doi.org/10.2967/jnumed.121.263229
Publikováno v:
J Nucl Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166167f3536f9db8e954f60dc385d419
https://pubmed.ncbi.nlm.nih.gov/35332094
https://pubmed.ncbi.nlm.nih.gov/35332094
Autor:
Victoria Florea, Angela C. Rieger, Alan W. Heldman, Makoto Natsumeda, Darcy L. DiFede, Aisha Khan, Mayra Vidro-Casiano, Raul Mitrani, Bryon A. Tompkins, Joshua M. Hare, Courtney Premer, Robert J. Myerburg, Ivonne Hernandez Schulman
Publikováno v:
EBioMedicine
EBioMedicine, Vol 48, Iss, Pp 377-385 (2019)
EBioMedicine, Vol 48, Iss, Pp 377-385 (2019)
Background: Non-ischemic dilated cardiomyopathy (NIDCM) responds variably to intramyocardial injection of mesenchymal stem cells (MSCs). We hypothesized that NIDCM genotype may influence responsiveness to MSC therapy and performed genotyping on all p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350946de011eeccae32f0ed5e7f8585d
http://europepmc.org/articles/PMC6838383
http://europepmc.org/articles/PMC6838383
Autor:
Rosemeire M. Kanashiro-Takeuchi, Alessandro Salerno, Andrew V. Schally, Amarylis C. B. A. Wanschel, Peter Buchwald, Joshua M. Hare, Ivonne Hernandez Schulman, Raul A Dulce, Victoria Florea, Marcos Rosado, Darren Turner, Luiza Bagno, Wayne Balkan, Angela C. Rieger, Jose Rodriguez, Lauro M Takeuchi
Publikováno v:
Proc Natl Acad Sci U S A
Therapies for heart failure with preserved ejection fraction (HFpEF) are lacking. Growth hormone-releasing hormone agonists (GHRH-As) have salutary effects in ischemic and nonischemic heart failure animal models. Accordingly, we hypothesized that GHR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e0f16ff5f30c21f6d4e44c06d044b9
https://pubmed.ncbi.nlm.nih.gov/33468654
https://pubmed.ncbi.nlm.nih.gov/33468654
Autor:
Victoria Florea, Angela C. Rieger, Jose Rodriguez, Raul A Dulce, Marcos Rosado, Luiza Bagno, Alessandro Salerno, Lauro M Takeuchi, Joshua M. Hare, Andrew V. Schally, Wayne Balkan, Ivonne Hernandez Schulman, Darren Turner
BackgroundTherapies that improve morbidity and mortality in heart failure with preserved ejection fraction (HFpEF) are lacking. Growth hormone releasing hormone analogues (GHRH-A) reverse fibrosis and improve cardiac function in ischemic and non-isch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::031b195935d8c32ffd2eb30ac11f818c
https://doi.org/10.1101/2020.05.30.111476
https://doi.org/10.1101/2020.05.30.111476
